| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |